Enliven Therapeutics
ELVN----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Enliven Therapeutics(ELVN) predict that the EBIT is -27.82 M (+12.21%), Beat estimate;the EPS is -0.38 (+33.33%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.03B12.21%
-0.03B1.18%
+0.00B13.39%
EPSExceed expectations
-0.3833.33%
-0.46518.42%
+0.085014.91%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf